Gradient Denervation Technologies
Gradient Denervation Technologies develops a minimally invasive, ultrasound-based catheter system designed to treat patients with pulmonary hypertension. The device performs pulmonary artery denervation by ablating nerves around the pulmonary artery using therapeutic ultrasound energy. The technology specifically targets patients with pulmonary hypertension due to left heart disease, a group currently lacking approved drug or device therapies.
Visit websiteSuresnes, France
Healthtech
Medical Devices
Funding summary
- Total raised
- €14.0M
- Funding rounds
- 1
Investors in Gradient Denervation Technologies
Investors on record for Gradient Denervation Technologies. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Gradient Denervation Technologies?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors